Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 5,251,000 | 5,454,000 | 5,345,000 | 5,434,000 | 5,011,000 |
| Cost of Goods | 1,303,000 | 1,367,000 | 1,407,000 | 1,481,000 | 1,343,000 |
| Gross Profit | 3,948,000 | 4,087,000 | 3,938,000 | 3,953,000 | 3,668,000 |
| Operating Expenses | 1,921,000 | 2,370,000 | 2,171,000 | 2,185,000 | 1,939,000 |
| Operating Income | 2,027,000 | 1,717,000 | 1,767,000 | 1,768,000 | 1,729,000 |
| Other Income | 0 | -123,000 | 63,000 | 22,000 | 38,000 |
| Pre-tax Income | 2,027,000 | 1,594,000 | 1,830,000 | 1,790,000 | 1,767,000 |
| Income Tax | 545,000 | 363,000 | 475,000 | 483,000 | 400,000 |
| Net Income Continuous | 1,482,000 | 1,231,000 | 1,355,000 | 1,307,000 | 1,367,000 |
| Minority Interests | 381,000 | 379,000 | 386,000 | 405,000 | 381,000 |
| Net Income | $1,101,000 | $852,000 | $969,000 | $902,000 | $986,000 |
| EPS Basic Total Ops | 0.65 | 0.50 | 0.57 | 0.53 | 0.58 |
| EPS Basic Continuous Ops | 0.88 | 0.73 | 0.80 | 0.77 | 0.80 |
| EPS Diluted Total Ops | 0.64 | 0.51 | 0.56 | 0.52 | 0.57 |
| EPS Diluted Continuous Ops | 0.87 | 0.72 | 0.79 | 0.76 | 0.80 |
| EBITDA(a) | $2,166,000 | $1,863,000 | $1,853,000 | $1,974,000 | $1,919,000 |